MedPath

Efficacy of tDCS in the Treatment of Resistant Auditory Hallucinations in Schizophrenia

Not Applicable
Recruiting
Conditions
Hallucinations
Refractory Schizophrenia
Schizophrenia
Interventions
Device: transcranial direct current stimulation
Registration Number
NCT04352569
Lead Sponsor
Centre hospitalier de Ville-Evrard, France
Brief Summary

The regions which are assumed to underlie the pathophysiology of schizophrenia, namely hypoactivity at the prefrontal level and pathological hyperactivity of the associative regions of the language located in the left temporoparietal region.

To assess the efficacy of tDCS on auditory hallucinations, the investigators performs an randomized double blind versus placebo trial. In each arms patients will receive two tDCS sessions a day during two weeks.

Detailed Description

Hearing hallucinations are one of the major symptoms of schizophrenia. In 30% of patients they are resistant to common psychotropic treatments. tDCS (Transcranial Direct Current Stimulation) is a technical of brain stimulation, non-invasive, painless that modulates brain activity by the transcranial administration of a low-intensity electric current, via two electrodes (an anode and a cathode). Several scientifics studies have reported a beneficial effect of tDCS in the treatment of pain, depression and especially hearing hallucinations in schizophrenia.

The main study purpose is to evaluate the effectiveness of tDCS on resistant auditory hallucinations in patients with schizophrenia.

Then, to evaluate the effectiveness of tDCS on global schizophrenic symptomatology and to assess the impact of tDCS on patients' quality of life.

Also the study, evaluate the impact of tDCS on cortical excitability. We measure the change in serum BDNF (Brain Derived Neutrophic Factor) before and after tDCS stimulation. Indeed, to evaluate the impact of tDCS on neurocognitive functions.

Patients will receive either active tDCS or placebo tDCS randomly. All patients will have two tDCS/day sessions, one hour apart, for 2 working weeks. The stimulation parameters will be consistent with the literature data, namely: Intensity = 2mA; duration of sessions = 20 minutes; total number of sessions = 20 (2 daily sessions for two working weeks).

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
44
Inclusion Criteria
  • Schizophrenia according to DSM-V.
  • Refractory auditory hallucinations(despite two antipsychotics trials).
  • Right-handed patients.
  • Written informed consent.
Exclusion Criteria
  • Presence of other psychiatric disorders than schizophrenia (except addiction to tobacco or caffeine ).
  • History of severe head trauma or coma.
  • History of epilepsy or neurological disorder or a general medical condition.
  • Presence of intracranial metallic objects or pacemaker.
  • Hospitalized patients without consent.
  • pregnant women .

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
transcranial direct current stimulation shamtranscranial direct current stimulationtDCS device allows sham stimulation. This technic give the same impression that active stimulation and allows optimum placebo stimulation.
transcranial direct current stimulationtranscranial direct current stimulationThe transcranial direct current stimulation (tDCS) with two elecrodes placed over the scalp: the anode over the LTP, le cathode over L DLPFG.
Primary Outcome Measures
NameTimeMethod
auditory hallucinations rating scale (AHRS)15 days after

AHRS is a scale frequently used to assess auditory hallucinations in schizophrenia studies (Hoffman et al. 2005).

Secondary Outcome Measures
NameTimeMethod
CGI15 days after

clinical global impression (Kadouri et al. 2007)

PANSS,15 days after

Positive and negative symptom scale (PANSS, Kay et al. 1988)

Trial Locations

Locations (1)

unité de recherche clinique de l'E.P.S de Ville Evrard

🇫🇷

Neuilly Sur Marne, France

© Copyright 2025. All Rights Reserved by MedPath